Loading...

PALI PALISADE BIO INC Capital Structure Changes 8-K Filing

PLSD

PL

PALISADE BIO INC

(PALI)

2026 8-K

Share Increase Approved

Phantom Equity Plan

Annual Meeting Summary

Corporate Update

Special Meeting Cancelled

Meeting Adjourned

Special Meeting Adjourned

Phantom Equity Plan

Rights Offerings

Delisting due to Non-Compli...

Public Offering

CEO Employment Agreement

Annual Meeting of Stockholders

Appointment of Margery Fisc...

Presentation at IBD Innovat...

Reverse Stock Split

Financial Results and Non-C...

Resignation and Bylaws Amen...

Resignation of Directors

Warrant Inducement Transaction

Disclosure and Preclinical ...

Presentation Update

Entry into Material Agreeme...

Registered Direct Offering ...

FDIC Control of SVB

Equity Compensation and Man...

Registered Direct Offering ...

External Links:

On March 27, 2026, Palisade Bio, Inc. issued 1,536,885 shares of its common stock for $3.0 million, or $1.952 per share, to an affiliate of Iterative Health to prepare for a Phase 2 study for ulcerative colitis.

AI Assistant

PALISADE BIO INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.